These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 7497946)
21. Changes in gene expression induced by carbamazepine and phenytoin: testing the danger hypothesis. Lu W; Li X; Uetrecht JP J Immunotoxicol; 2008 Apr; 5(2):107-13. PubMed ID: 18569379 [TBL] [Abstract][Full Text] [Related]
22. The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy. Wesnes KA; Edgar C; Dean AD; Wroe SJ Epilepsy Behav; 2009 Mar; 14(3):522-8. PubMed ID: 19111629 [TBL] [Abstract][Full Text] [Related]
23. Phenytoin-induced DRESS with cross-reactivity to carbamazepine in a 10-year-old Indian child. Mendiratta V; Bhushan P Clin Exp Dermatol; 2006 Sep; 31(5):720-1. PubMed ID: 16901324 [No Abstract] [Full Text] [Related]
29. [Drug-induced pseudolymphoma with predominantly cutaneous manifestation]. Sigal M; Pulik M Ann Dermatol Venereol; 1993; 120(2):175-80. PubMed ID: 8363313 [No Abstract] [Full Text] [Related]
30. Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability. Iivanainen M J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():24-31. PubMed ID: 10030428 [TBL] [Abstract][Full Text] [Related]
31. Carbamazepine in the treatment of epilepsy in people with intellectual disability. Waisburg H; Alvarez N J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():36-40. PubMed ID: 10030430 [TBL] [Abstract][Full Text] [Related]
32. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. Mauri-Hellweg D; Bettens F; Mauri D; Brander C; Hunziker T; Pichler WJ J Immunol; 1995 Jul; 155(1):462-72. PubMed ID: 7602118 [TBL] [Abstract][Full Text] [Related]
33. Chronic prenatal exposure to carbamazepine and behavior effects on mice offspring. Rayburn WF; Gonzalez CL; Parker KM; Christensen HD Am J Obstet Gynecol; 2004 Feb; 190(2):517-21. PubMed ID: 14981399 [TBL] [Abstract][Full Text] [Related]
34. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients. Yegnanarayan R; Mahesh SD; Sangle S Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216 [TBL] [Abstract][Full Text] [Related]
35. The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children. Viinikainen K; Eriksson K; Mönkkönen A; Aikiä M; Nieminen P; Heinonen S; Kälviäinen R Epilepsy Behav; 2006 Dec; 9(4):636-40. PubMed ID: 17049311 [TBL] [Abstract][Full Text] [Related]
36. The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs. Holmes LB; Coull BA; Dorfman J; Rosenberger PB J Pediatr; 2005 Jan; 146(1):118-22. PubMed ID: 15644835 [TBL] [Abstract][Full Text] [Related]
38. Computerized task battery assessment of cognitive and performance effects of acute phenytoin motion sickness therapy. Chelen W; Ahmed N; Kabrisky M; Rogers S Aviat Space Environ Med; 1993 Mar; 64(3 Pt 1):201-5. PubMed ID: 8447800 [TBL] [Abstract][Full Text] [Related]
39. Phenytoin-carbamazepine cross-sensitivity. Reents SB; Luginbuhl WE; Davis SM DICP; 1989 Mar; 23(3):235-6. PubMed ID: 2718502 [TBL] [Abstract][Full Text] [Related]
40. Dilantin dementia. Rosen JA Trans Am Neurol Assoc; 1968; 93():273. PubMed ID: 5711038 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]